Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-8.96%
0%
-8.96%
6 Months
-15.08%
0%
-15.08%
1 Year
-32.85%
0%
-32.85%
2 Years
-1.74%
0%
-1.74%
3 Years
1.23%
0%
1.23%
4 Years
-38.2%
0%
-38.2%
5 Years
-7.47%
0%
-7.47%
Bure Equity AB for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-27.50%
EBIT Growth (5y)
6.27%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
3.55%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
19.72%
ROE (avg)
18.65%
Valuation key factors
Factor
Value
P/E Ratio
3
Industry P/E
Price to Book Value
0.97
EV to EBIT
3.38
EV to EBITDA
3.38
EV to Capital Employed
0.97
EV to Sales
91.91
PEG Ratio
0.17
Dividend Yield
1.02%
ROCE (Latest)
28.62%
ROE (Latest)
27.84%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
193.00
54.00
257.41%
Operating Profit (PBDIT) excl Other Income
-1,250.00
-2,636.00
52.58%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-1,250.00
-2,631.00
52.49%
Operating Profit Margin (Excl OI)
-6,481.90%
-48,833.30%
4,235.14%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is 257.41% vs 575.00% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is 52.49% vs -103.80% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
210.00
206.00
1.94%
Operating Profit (PBDIT) excl Other Income
5,707.00
4,734.00
20.55%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
5,735.00
4,749.00
20.76%
Operating Profit Margin (Excl OI)
27,152.40%
22,956.30%
419.61%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 1.94% vs -7.21% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 20.76% vs 151.42% in Dec 2023
About Bure Equity AB 
Bure Equity AB
Finance
Bure Equity AB is a Sweden-based investment company. The Company specializes in long-term owning, developing, as well as disposing listed and unlisted operating entities. Its holding portfolio comprises eight firms: Cavotec, an engineering group that delivers power transmission, distribution and control technologies to a range of areas; MedCap, which owns and develops companies involved in the Life Science sector; Mycronic, which designs and manufactures laser-based pattern generators that are used in the flexible electronics production; PartnerTech, providing product development, as well as production, logistics and aftermarket services; Vitrolife, a developer and producer of solutions for fertility treatment; XVIVO Perfusion AB, which focuses on organ, tissue and cell preservation in relation with transplantation; Investment AB Bure, which owns and manages leasing of locomotives; and Mercuri International, which offers sales and management training consultancy.
Company Coordinates 
Company Details
Nybrogatan 6 , STOCKHOLM None : 114 34
Registrar Details






